Literature DB >> 7562004

Growth inhibition of rat glioma cells in vitro and in vivo by aspirin.

A T Aas1, T I Tønnessen, A Brun, L G Salford.   

Abstract

The effect of non-steroidal anti-inflammatory drugs (NSAIDs), acetylsalicylic acid (commonly known as aspirin), salicylic acid, piroxicam and indomethacin on the growth of rat glioma cells (RG 2) in vitro and aspirin in vivo was studied. The in vitro studies reveal that aspirin and salicylic acid strongly inhibit growth of rat glioma (RG 2) cells in concentrations used in medicine for treatment of rheumatic diseases. On the other hand, indomethacin and piroxicam had no effect, indicating that the inhibitory effect on tumor growth is not due to the inhibition of prostaglandin synthesis. The synthesis of ATP was markedly reduced (34% of control) in the presence of drugs, whereas protein synthesis measured as 3H-leucine incorporation was slightly more inhibited (73% of control) than cell growth. Aspirin administered to Fischer 344 rats inhibited growth of RG 2 cells inoculated into the caudate nucleus in vivo, both when administered the day before inoculation of tumor cells and when tumors had formed, i.e. 5 days post inoculation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562004     DOI: 10.1007/BF01078487

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Mitogen-independent activation of Na+/H+ exchange in human epidermoid carcinoma A431 cells: regulation by medium osmolarity.

Authors:  D Cassel; B Whiteley; Y X Zhuang; L Glaser
Journal:  J Cell Physiol       Date:  1985-02       Impact factor: 6.384

2.  Requirement of the Na+/H+ exchanger for tumor growth.

Authors:  D Rotin; D Steele-Norwood; S Grinstein; I Tannock
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

3.  Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse.

Authors:  V Hial; Z Horakova; F E Shaff; M A Beaven
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432

4.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

5.  Effect of anti-inflammatory analgesic drugs on the regulation of cytosolic pH by anion antiport.

Authors:  T I Tønnessen; A T Aas; K Sandvig; S Olsnes
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

6.  Effect of ibuprofen on tumor growth in the C6 spheroid implantation glioma model.

Authors:  C L Farrell; J Megyesi; R F Del Maestro
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

7.  Phorbol ester and diacylglycerol mimic growth factors in raising cytoplasmic pH.

Authors:  W H Moolenaar; L G Tertoolen; S W de Laat
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  Ten-year survival among patients with supratentorial astrocytomas grade III and IV.

Authors:  L G Salford; A Brun; S Nirfalk
Journal:  J Neurosurg       Date:  1988-10       Impact factor: 5.115

9.  Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.

Authors:  R D Oberhaensli; D Hilton-Jones; P J Bore; L J Hands; R P Rampling; G K Radda
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

10.  Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment.

Authors:  A R Karuri; E Dobrowsky; I F Tannock
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more
  11 in total

1.  Acetaminophen selectively reduces glioma cell growth and increases radiosensitivity in culture.

Authors:  D Casper; R Lekhraj; U S Yaparpalvi; A Pidel; W A Jaggernauth; P Werner; S Tribius; J D Rowe; P A LaSala
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.

Authors:  Maode Wang; Daizo Yoshida; Shouxun Liu; Akira Teramoto
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

Review 3.  Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Victor A Levin
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

4.  Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.

Authors:  Bing Xin; Yoshihito Yokoyama; Tatsuhiko Shigeto; Hideki Mizunuma
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

5.  Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.

Authors:  Muneaki Matsuo; Nobuyuki Yoshida; Masahumi Zaitsu; Kiyohisa Ishii; Yuhei Hamasaki
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

6.  The RG2 rat glioma model.

Authors:  A T Aas; A Brun; C Blennow; S Strömblad; L G Salford
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 7.  The eicosanoid cascade: possible role in gliomas and meningiomas.

Authors:  N Nathoo; G H Barnett; M Golubic
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

8.  Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.

Authors:  Marc A Brockmann; Alf Giese; Kathrin Mueller; Finjap Janvier Kaba; Frank Lohr; Christel Weiss; Stefan Gottschalk; Ingo Nolte; Jan Leppert; Jochen Tuettenberg; Christoph Groden
Journal:  Neuro Oncol       Date:  2007-05-15       Impact factor: 12.300

9.  Survival as a Function of Nonsteroidal Anti-inflammatory Drug Use in Patients with Glioblastoma.

Authors:  Ryan P Bruhns; Whitney S James; Mohammad Torabi; Mark Borgstrom; Adam Roussas; Michael Lemole
Journal:  Cureus       Date:  2018-09-10

10.  Increasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cells.

Authors:  Georg Bauer
Journal:  Redox Biol       Date:  2015-08-24       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.